Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Blair-West

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|February 18, 2005
Clinical practice guidelinesScott Blair-West
Australian Family Physician|September 12, 2013
Obsessive-compulsive disorder--the role of the GPCaroline Johnson, Scott Blair-West
Journal of Clinical Psychology|November 9, 2017
Emotion regulation difficulties in obsessive-compulsive disorderKeong Yap, Christopher Mogan, Anna Moriarty, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 28, 2015
N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic reviewGeorgina Oliver, Olivia Dean, David Camfield, et al.
CNS Drugs|September 17, 2015
N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled StudyJerome Sarris, Georgina Oliver, David A Camfield, et al.
The Australian and New Zealand Journal of Psychiatry|October 3, 2017
Deep brain stimulation for severe treatment-resistant obsessive-compulsive disorder: An open-label case seriesSarah Farrand, Andrew H Evans, Simone Mangelsdorf, et al.
CNS Spectrums|June 24, 2021
Treatment of refractory obsessive-compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot studyJerome Sarris, Gerard J Byrne, Georgina Oliver, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 19, 2022
N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trialJerome Sarris, Gerard Byrne, David Castle, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|February 18, 2005
Clinical practice guidelinesScott Blair-West
Australian Family Physician|September 12, 2013
Obsessive-compulsive disorder--the role of the GPCaroline Johnson, Scott Blair-West
Journal of Clinical Psychology|November 9, 2017
Emotion regulation difficulties in obsessive-compulsive disorderKeong Yap, Christopher Mogan, Anna Moriarty, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 28, 2015
N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic reviewGeorgina Oliver, Olivia Dean, David Camfield, et al.
CNS Drugs|September 17, 2015
N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled StudyJerome Sarris, Georgina Oliver, David A Camfield, et al.
The Australian and New Zealand Journal of Psychiatry|October 3, 2017
Deep brain stimulation for severe treatment-resistant obsessive-compulsive disorder: An open-label case seriesSarah Farrand, Andrew H Evans, Simone Mangelsdorf, et al.
CNS Spectrums|June 24, 2021
Treatment of refractory obsessive-compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot studyJerome Sarris, Gerard J Byrne, Georgina Oliver, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 19, 2022
N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trialJerome Sarris, Gerard Byrne, David Castle, et al.
Pageof 1